Skip to main content

Animations

MJFF Publications

3701 - 3710 of 6560 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2023
  • 2025
  • 2014
  • 2018
  • 2020
  • 2024
  • 2020
  • 2017
  • Summary Details
    OPEN
    Title: Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and Analogs
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00597
    Citation Count: 65
  • Summary Details
    OPEN
    Title: Aromaticity at position 39 in α‐synuclein: A modulator of amyloid fibril assembly and membrane‐bound conformations
    Journal Name: Protein Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/pro.4360
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Distribution of cholinergic nerve terminals in the aged human brain measured with [18F]FEOBV PET and its correlation with histological data
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2023.119908
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Neuroimaging-based data-driven subtypes of spatiotemporal atrophy due to Parkinson’s disease
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcaf146
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2013.12.011
    Citation Count: 88
  • Summary Details
    OPEN
    Title: Myosin VI-Dependent Actin Cages Encapsulate Parkin-Positive Damaged Mitochondria
    Journal Name: Developmental Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.devcel.2018.01.007
    Citation Count: 112
  • Summary Details
    OPEN
    Title: Impact ofGBA1variants on long-term clinical progression and mortality in incident Parkinson’s disease
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1136/jnnp-2020-322857
    Citation Count: 95
  • Summary Details
    OPEN
    Title: Clinical and genetic characterization of a progressive RBL2-associated neurodevelopmental disorder
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awae363
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Contingent negative variation: a biomarker of abnormal attention in functional movement disorders
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1111/ene.14189
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Major Shifts in Glial Regional Identity Are a Transcriptional Hallmark of Human Brain Aging
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2016.12.011
    Citation Count: 429
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.